US HB2905 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 16-9)
Status: Introduced on May 22 2019 - 25% progression, died in committee
Action: 2019-05-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 22 2019 - 25% progression, died in committee
Action: 2019-05-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
Title
Medicare IVIG Access Enhancement Act
Sponsors
| Rep. Earl Blumenauer [D-OR] | Rep. George Holding [R-NC] | Rep. G. Butterfield [D-NC] | Rep. Robin Kelly [D-IL] |
| Rep. John Garamendi [D-CA] | Rep. Terri Sewell [D-AL] | Rep. Kenny Marchant [R-TX] | Rep. Susan Davis [D-CA] |
| Rep. Mike Kelly [R-PA] | Rep. Elaine Luria [D-VA] | Rep. Dwight Evans [D-PA] | Rep. Doris Matsui [D-CA] |
| Rep. Adrian Smith [R-NE] | Rep. David Price [D-NC] | Rep. Ron Kind [D-WI] | Rep. Susan Brooks [R-IN] |
| Rep. Lacy Clay [D-MO] | Rep. Brian Fitzpatrick [R-PA] | Rep. Julia Brownley [D-CA] | Rep. Jerrold Nadler [D-NY] |
| Rep. James McGovern [D-MA] | Rep. Jenniffer Gonzalez-Colon [R-PR] | Rep. Christopher Smith [R-NJ] | Rep. Debbie Lesko [R-AZ] |
| Rep. Max Rose [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-05-23 | House | Referred to the Subcommittee on Health. |
| 2019-05-23 | House | Referred to the Subcommittee on Energy. |
| 2019-05-22 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-05-22 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-05-22 | House | Sponsor introductory remarks on measure. (CR E657) |
| 2019-05-22 | House | Introduced in House |
Subjects
Congressional oversight
Drug therapy
Government studies and investigations
Health
Home and outpatient care
Medicare
Neurological disorders
Drug therapy
Government studies and investigations
Health
Home and outpatient care
Medicare
Neurological disorders
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/2905/all-info |
| Text | https://www.congress.gov/116/bills/hr2905/BILLS-116hr2905ih.pdf |
